Mattias Paulsson obtained his pharmacist degree at Uppsala University, Sweden, in 1997. Thereafter he started his PhD project at the Department of Pharmacy/Pharmaceutics, Uppsala University presenting his thesis “Controlled Release Gel Formulations for Mucosal Drug Delivery” in 2001. In the thesis, physicochemical principles of pharmacy are used for formulation development for clinical applications. Dr. Paulsson has held positions as formulation scientist at both Cederroth International and Fresenius Kabi. He has been heading the extemporaneous compounding unit of Uppsala University Hospital, preparing radiopharmaceuticals, chemotherapy and other aseptically prepared medications as well as managing the clinical trials unit. He has been a qualified person and held positions with GMP responsibility for compounding units at some Swedish hospitals.
In 2014 he started working with a more clinical approach at the Uppsala University Children’s Hospital with patient safety and optimizing the use of medications from a formulation point of view. He has configured and developed the medication modules of the PDMS system (MetaVision) used at the hospital including the NICU. He holds the position of QPPV (Qualified person pharmacovigilance) for the PET centre at the hospital. He has been managing projects to build new clean rooms, hire staff, purchasing equipment (including chemotherapy robotic automation) and in‐sourcing of extemporaneous compounding units for radiotherapy, chemotherapy and miscellaneous aseptic preparations. From 2019 he is deputy chief pharmacist at Uppsala University Hospital and has several research projects running.
He is involved in both undergraduate and post graduate training of pharmacist in the areas: Parenteral nutrition, IV compatibility, 3D printing, Formulation Science and Compounding. He is supervising three PhD students at Uppsala university
He has been chairman for the Scandinavian Paediatric Pharmacist Group for 2017‐2019 and he was in the steering committee of the ePed Best practice initiative (www.eped.se) for safe handling of paediatric medications based on the EU resolution on medication handling quality. He is a member of UK based Neonatal and Paediatric Pharmacists Group (NPPG) and the Swedish Pharmaceutical Society.
Linkedin profile: https://www.linkedin.com/in/mattias‐paulsson‐1957239/
Research gate profile: https://www.researchgate.net/profile/Mattias_Paulsson
